BamSEC and AlphaSense Join Forces
Learn More

Akebia Therapeutics Inc.

NASDAQ: AKBA    
Share price (1/8/25): $1.79    
Market cap (1/8/25): $391 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.2
from S-3 46 pages Amended & Restated Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 43 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 42 pages 11,000,000 Shares Akebia Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 46 pages Akebia Therapeutics, Inc. Shares of Common Stock (Par Value $0.00001 Per Share) Controlled Equity Offeringsm Amended and Restated Sales Agreement
12/34/56
EX-1.1
from 8-K 34 pages 8,500,000 Shares Akebia Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages 4,000,000 Shares Akebia Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1.1
from S-3 45 pages Akebia Therapeutics, Inc. Shares of Common Stock (Par Value $0.00001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from 8-K 36 pages 7,250,000 Shares Akebia Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 45 pages Akebia Therapeutics, Inc. Shares of Common Stock (Par Value $0.00001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from 8-K 35 pages 7,272,727 Shares Akebia Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56
EX-1
from SC 13G 2 pages Agreement Dated as of February 6, 2015 by and Among Venture Investors Early Stage Fund IV Limited Partnership; Venture Investors LLC and Viesf IV GP LLC (The “Reporting Persons”)
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 39 pages Shares Akebia Therapeutics, Inc. Common Stock, Par Value $0.00001 Per Share Underwriting Agreement
12/34/56